Comment on: Clinical Characteristics, Diagnosis, and Treatments for COVID-19

References

[1] XieNN, ZhangWC, ChenJ, et al.. Clinical Characteristics, Diagnosis, and Therapeutics of COVID-19: A Review. Curr Med Sci, 2023, 43(6): 1066-1074

[2] SuekiH, MizukawaY, AoyamaY. Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients. J Dermatol, 2018, 45(1): 3-9

[3] MertensJ, LaghribY, KenyonC. A Case of Steroid-Responsive, COVID-19 Immune Reconstitution Inflammatory Syndrome Following the Use of Granulocyte Colony-Stimulating Factor. Open Forum Infect Dis, 2020, 7(8): ofaa326

[4] Garcia-CarreteroR, Vazquez-GomezO, Ordonez-GarciaM. Delayed Immune Reconstitution Inflammatory Syndrome in an Immunosuppressed Patient With SARS-CoV-2. Cureus, 2021, 13(11): e19481

[5] LalondeCS, ZhuangTZ, AldredgeAA, et al.. Abstract 444: COVID-IRIS: Immune reconstitution after G-CSF administration for neutropenia during acute COVID-19 infection. Cancer Res, 2022, 82(12_Supplement): 444

[6] Canelas MendesC, Howell MonteiroP, Madeira LopesJ, et al.. Paradoxical Immune Reconstitution Inflammatory Syndrome in SARS-CoV-2 Infection After Improvement of Chemotherapy-Induced Aplasia. Cureus, 2023, 15(10): e46723

[7] PourshahidS, KhademolhosseiniS, GiriB, et al.. A Case of Steroid-Responsive Severe Pneumonia Following a Recent COVID-19 Infection in a Patient With Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection. Cureus, 2022, 14(7): e26785

[8] NangraniK, PatelD, KumariA, et al.. Immune Reconstitution Inflammatory Syndrome After Use of Anti-Retroviral Therapy in Covid-19. Chest, 2021, 160(4): 309A-310A

[9] AutranB, CarcelainG, LiTS, et al.. Positive effects of combined antiretroviral therapy on CD4+ T-cell homeostasis and function in advanced HIV disease. Science, 1997, 277(5322): 112-116

[10] VinhaesCL, Araujo-PereiraM, TiburcioR, et al.. Systemic Inflammation Associated with Immune Reconstitution Inflammatory Syndrome in Persons Living with HIV. Life (Basel), 2021, 11(1): 65

[11] SeddikiN, FrenchM. COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire. Front Immunol, 2021, 12: 649567

[12] ArmangeL, LacroixA, PetitgasP, et al.. The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review. Eur J Clin Microbiol Infect Dis, 2023, 42(4): 413-422